Comparison of ureteroscopic lithotripsy and laparoscopic ureterolithotomy in the treatment of large proximal ureteral stones in developing countries: a systematic review and meta-analysis

输尿管镜碎石术与腹腔镜输尿管切开取石术治疗发展中国家大型近端输尿管结石的比较:系统评价和荟萃分析

阅读:1

Abstract

BACKGROUND: Ureteral stones are common disorders of the urinary system, and larger proximal stones (>10 mm) often require surgical intervention due to their difficulty in passing naturally. The optimal surgical approach remains a matter of debate. This study compares the efficacy and safety of ureteroscopic lithotripsy (URSL) and laparoscopic ureterolithotomy (LU) for large proximal ureteral stones to inform clinical decisions. METHOD: A systematic review was conducted, encompassing randomized controlled trials (RCTs) from PubMed, Embase, Web of Science, Cochrane Library, and ResearchGate. RESULT: For our primary outcomes, LU demonstrated a significant benefit over URSL in terms of overall success rate, stone-free rate (SFR), initial SFR, SFR at 3 weeks, SFR at 1 month, and SFR at discharge, reducing the need for auxiliary treatment, lowering the residual calculi rate. LU significantly reduced the incidence of various complications. Specifically, among patients treated with LU, the occurrence of Clavien-Dindo Grade 2 and 3 complications is lower. Additionally, the incidence of mucosal injury, stone retropulsion, ureteral perforation, ureteral stenosis, and urinary tract infection is also lower in patients treated with LU. According to our subgroup analysis, both transperitoneal laparoscopic ureterolithotomy (TLU) and retroperitoneal laparoscopic ureterolithotomy (RLU) improved SFR, reduced the need for auxiliary treatment and stone retropulsion compared to URSL. CONCLUSION: Compared with URSL, LU demonstrates a higher SFR and fewer complications for patients with proximal ureteral stones larger than 10 mm.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。